Comparison Overview

Hetero Drugs Ltd

VS

Fresenius Kabi

Hetero Drugs Ltd

India Hyderabad, 500018, IN
Last Update: 2025-12-09
Between 750 and 799

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 10,001
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Fresenius Kabi

Else-Kröner-Straße 1, Bad Homburg, 61352, DE
Last Update: 2025-12-10

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 23,769
Subsidiaries: 41
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/hetero-drugs-ltd.jpeg
Hetero Drugs Ltd
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/freseniuskabi.jpeg
Fresenius Kabi
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Hetero Drugs Ltd
100%
Compliance Rate
0/4 Standards Verified
Fresenius Kabi
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Hetero Drugs Ltd in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Fresenius Kabi in 2025.

Incident History — Hetero Drugs Ltd (X = Date, Y = Severity)

Hetero Drugs Ltd cyber incidents detection timeline including parent company and subsidiaries

Incident History — Fresenius Kabi (X = Date, Y = Severity)

Fresenius Kabi cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/hetero-drugs-ltd.jpeg
Hetero Drugs Ltd
Incidents

No Incident

https://images.rankiteo.com/companyimages/freseniuskabi.jpeg
Fresenius Kabi
Incidents

Date Detected: 05/2020
Type:Ransomware
Attack Vector: Computer virus outbreak
Blog: Blog

FAQ

Fresenius Kabi company demonstrates a stronger AI Cybersecurity Score compared to Hetero Drugs Ltd company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Fresenius Kabi company has historically faced a number of disclosed cyber incidents, whereas Hetero Drugs Ltd company has not reported any.

In the current year, Fresenius Kabi company and Hetero Drugs Ltd company have not reported any cyber incidents.

Fresenius Kabi company has confirmed experiencing a ransomware attack, while Hetero Drugs Ltd company has not reported such incidents publicly.

Neither Fresenius Kabi company nor Hetero Drugs Ltd company has reported experiencing a data breach publicly.

Neither Fresenius Kabi company nor Hetero Drugs Ltd company has reported experiencing targeted cyberattacks publicly.

Neither Hetero Drugs Ltd company nor Fresenius Kabi company has reported experiencing or disclosing vulnerabilities publicly.

Neither Hetero Drugs Ltd nor Fresenius Kabi holds any compliance certifications.

Neither company holds any compliance certifications.

Fresenius Kabi company has more subsidiaries worldwide compared to Hetero Drugs Ltd company.

Fresenius Kabi company employs more people globally than Hetero Drugs Ltd company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Hetero Drugs Ltd nor Fresenius Kabi holds SOC 2 Type 1 certification.

Neither Hetero Drugs Ltd nor Fresenius Kabi holds SOC 2 Type 2 certification.

Neither Hetero Drugs Ltd nor Fresenius Kabi holds ISO 27001 certification.

Neither Hetero Drugs Ltd nor Fresenius Kabi holds PCI DSS certification.

Neither Hetero Drugs Ltd nor Fresenius Kabi holds HIPAA certification.

Neither Hetero Drugs Ltd nor Fresenius Kabi holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

PCSX2 is a free and open-source PlayStation 2 (PS2) emulator. In versions 2.5.377 and below, an unchecked offset and size used in a memcpy operation inside PCSX2's CDVD SCMD 0x91 and SCMD 0x8F handlers allow a specially crafted disc image or ELF to cause an out-of-bounds read from emulator memory. Because the offset and size is controlled through MG header fields, a specially crafted ELF can read data beyond the bounds of mg_buffer and have it reflected back into emulated memory. This issue is fixed in version 2.5.378.

Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Aircompressor is a library with ports of the Snappy, LZO, LZ4, and Zstandard compression algorithms to Java. In versions 3.3 and below, incorrect handling of malformed data in Java-based decompressor implementations for Snappy and LZ4 allow remote attackers to read previous buffer contents via crafted compressed input. With certain crafted compressed inputs, elements from the output buffer can end up in the uncompressed output, potentially leaking sensitive data. This is relevant for applications that reuse the same output buffer to uncompress multiple inputs. This can be the case of a web server that allocates a fix-sized buffer for performance purposes. There is similar vulnerability in GHSA-cmp6-m4wj-q63q. This issue is fixed in version 3.4.

Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was found in itsourcecode COVID Tracking System 1.0. Affected by this vulnerability is an unknown functionality of the file /admin/?page=zone. The manipulation of the argument ID results in sql injection. The attack may be launched remotely. The exploit has been made public and could be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability has been found in itsourcecode COVID Tracking System 1.0. Affected is an unknown function of the file /admin/login.php of the component Admin Login. The manipulation of the argument Username leads to sql injection. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A flaw has been found in campcodes Online Student Enrollment System 1.0. This impacts an unknown function of the file /admin/register.php. Executing manipulation of the argument photo can lead to unrestricted upload. The attack can be launched remotely. The exploit has been published and may be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X